Found 5 matching trials
A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
PHASE3This is a multicenter, randomized, open-label, controlled phase III clinica...
Location
Multiple Locations
A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
PHASE2This is a phase II, multicentre clinical study investigating HS-20093 or SH...
Location
Nanjing Drum Tower Hospital
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
PHASE3This is a randomized, controlled, open, multicenter phase III clinical stud...
Status
Active Not Recruiting
Location
Beijing Jishuitan Hospital affiliated to Capital Medical University
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
PHASE1HS-20093 is a humanized IgG1 antibody-drug conjugate (ADC) which specifical...
Location
Zhongshan Hospital Fudan University
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
PHASE1This study aims to evaluate the safety, tolerability, and efficacy of HRS-2...
Location
the First Affiliated Hospital, School of Medicine